Functional differences between Hsp105/110 family proteins in cell proliferation, cell division, and drug sensitivity.
Hiroko TeshimaHiroko WatanabeRyuji YasutakeYuki IkedaYukiko YonezuNamiko OkamotoAyana KakihanaRyuzaburo YukiYuji NakayamaYouhei SaitoPublished in: Journal of cellular biochemistry (2021)
The mammalian HSP105/110 family consists of four members, including Hsp105 and Apg-1, which function as molecular chaperones. Recently, we reported that Hsp105 knockdown increases sensitivity to the DNA-damaging agent Adriamycin but decreases sensitivity to the microtubule-targeting agent paclitaxel. However, whether the other Hsp105/110 family proteins have the same functional property is unknown. Here, we show that Apg-1 has different roles from Hsp105 in cell proliferation, cell division, and drug sensitivity. We generated the Apg-1-knockdown HeLa S3 cells by lentiviral expression of Apg-1-targeting short hairpin RNA. Knockdown of Apg-1 but not Hsp105 decreased cell proliferation. Apg-1 knockdown increased cell death upon Adriamycin treatment without affecting paclitaxel sensitivity. The cell synchronization experiment suggests that Apg-1 functions in mitotic progression at a different mitotic subphase from Hsp105, which cause difference in paclitaxel sensitivity. Since Apg-1 is overexpressed in certain types of tumors, Apg-1 may become a potential therapeutic target for cancer treatment without causing resistance to the microtubule-targeting agents.
Keyphrases
- heat shock protein
- heat shock
- heat stress
- cell proliferation
- cell cycle
- single cell
- cell death
- cell therapy
- cancer therapy
- poor prognosis
- induced apoptosis
- mesenchymal stem cells
- oxidative stress
- climate change
- emergency department
- drug delivery
- cell free
- signaling pathway
- long non coding rna
- nucleic acid
- circulating tumor